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Available online 23 June 2016Childhood adversity increases the risk of psychosis in adulthood. Theoretical and animal models suggest that this
effect may be mediated by increased striatal dopamine neurotransmission. The primary objective of this study
was to examine the relationship between adversity in childhood and striatal dopamine function in early adult-
hood. Secondary objectives were to compare exposure to childhood adversity and striatal dopamine function
in young people at ultra high risk (UHR) of psychosis and healthy volunteers. Sixty-seven young adults, compris-
ing 47 individuals at UHR for psychosis and 20 healthy volunteers were recruited from the same geographic area
and were matched for age, gender and substance use. Presynaptic dopamine function in the associative striatum
was assessed using 18F-DOPA positron emission tomography. Childhood adversity was assessed using the Child-
hood Experience of Care and Abuse questionnaire. Within the sample as a whole, both severe physical or sexual
abuse (T63 = 2.92; P= 0.005), and unstable family arrangements (T57 = 2.80; P= 0.007) in childhood were
associated with elevated dopamine function in the associative striatum in adulthood. Comparison of the UHR
and volunteer subgroups revealed similar incidence of childhood adverse experiences, and there was no signiﬁ-
cant group difference in dopamine function. This study provides evidence that childhood adversity is linked to
elevated striatal dopamine function in adulthood.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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social defeat1. Introduction
Traumatic experiences during childhood, such as physical, sexual or
psychological abuse, increase the risk of mental illness in adulthood
threefold (Varese et al., 2012). The neurobiological basis of this effect
is unknown. However, exposure to sustained environmental stress ele-
vates central dopaminergic neurotransmission in animal models
(Antelman et al., 1980; Tidey and Miczek, 1996; Valenti et al., 2011),
and an elevation in brain dopamine function is one of the most robust
neurobiological features of psychosis (Howes et al., 2012). It has thus
been suggested that psychosocial stress in childhood may increase the
risk of psychosis in later life through an effect on dopaminergic neuro-
transmission (Howes et al., 2004; Selten et al., 2013; Thompson et al.,
2004).
There is indirect evidence to support this notion from human neuro-
imaging studies. Healthy volunteers who have experienced childhood
trauma show an elevated dopaminergic response to amphetamine ad-
ministration, which may be mediated by perceived stress (Oswald et. This is an open access article underal., 2014). In addition, striatal dopamine release elicited by an acute psy-
chosocial stress task is elevated in healthy college students who experi-
enced low levels of maternal care during childhood (Pruessner et al.,
2004), suggesting that childhood disadvantage may be associated with
elevated dopaminergic responses to stress in later life. Compared to
healthy volunteers, an elevated dopaminergic response to this stress
task is also seen in adults who are at high risk for psychosis, adults
with schizotypy, and patients with schizophrenia (Mizrahi et al., 2012;
Soliman et al., 2008).
The social defeat hypothesis (Selten and Cantor-Graae, 2005; Selten
et al., 2013) posits that repeated setbacks in social situations leads to a
sensitization of mesostriatal dopamine neurotransmission, and thereby
increases the risk of developing psychotic symptoms. Childhood trauma
may represent one particular type of social defeat. In support of the so-
cial defeat hypothesis, it has recently been reported that amphetamine-
stimulated dopamine release in the striatum is elevated in young adults
with severe hearing impairment, who generally experience marked so-
cial exclusion (Gevonden et al., 2014).
The aim of the present study was to further examine how exposure
to adversity in childhood impacts on striatal dopamine function in
adulthood, in both a healthy volunteer group, and also a group at whothe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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striatal dopamine function and the incidence of childhood adversity
tend to be higher in UHR groups, although to a lesser extent than in
schizophrenia (Binbay et al., 2012; Egerton et al., 2013; Howes et al.,
2009; Mizrahi et al., 2012). The primary hypothesis was that striatal
presynaptic dopamine function would be elevated in both UHR and
healthy volunteers who experienced childhood adversity. As previous
studies have shown elevated dopamine responses in healthy volunteers
who experienced childhood adversity (Oswald et al., 2014; Pruessner et
al., 2004), we predicted that this relationshipwould be seen across both
groups, but to a greater degree in the UHR sample. Related to this, the
secondary hypotheses were that exposure to childhood adversity
would be higher in the UHR than healthy volunteer group, and that
striatal presynaptic dopamine function would be elevated in the UHR
compared to the healthy volunteer group. A further hypothesis was
that both striatal presynaptic dopamine and childhood adversity
would be positively related to the severity of psychotic symptoms.
2. Participants and methods
2.1. Participants
This study had National Health Service Research Ethics Committee
and Administration of Radioactive Substances Advisory Committee ap-
proval. All participants provided their written informed consent. One
group consisted of 47 individuals whomet operationalized UHR criteria
(over the last year, experience of attenuated psychotic symptoms, or
psychotic symptoms that lasted less than a week and spontaneously re-
mitted, or schizotypal personality disorder or a ﬁrst degree relativewith
a psychotic disorder plus a decline in functioning) (Phillips et al., 2000)
recruited from Outreach and Support in South London (OASIS), part of
the South London andMaudsley National Health Service Trust. A second
group comprised 20 healthy volunteers (Control), recruited from the
same geographic area by public advertisement. They had no personal
or family history of psychiatric symptoms, andwere not taking psycho-
tropic medication. Both groups included subjects who had participated
in previous dopamine imaging studies (Egerton et al., 2013; Howes et
al., 2011a, 2009), and represent those participants in whom there was
existing cross-over with a separate study on childhood adversity, or
thosewhom could be re-contacted to complete the childhood adversity
questionnaire.
2.2. Assessment of clinical variables and childhood adversity
Psychopathology was assessed using the Comprehensive Assess-
ment of At-Risk Mental States (CAARMS) (Phillips et al., 2000), Positive
and Negative Syndrome Scale for Schizophrenia (PANSS) (Kay et al.,
1987), and the Hamilton Depression and Anxiety Rating Scales
(Hamilton, 1959, 1960).
Childhood adversitywas assessed using the Childhood Experience of
Care and Abuse Questionnaire (CECA-Q) (Bifulco et al., 2005). Partici-
pants did not have to answer any questions they were uncomfortable
with. The following adverse events were analysed: A) death or separa-
tion from either parental ﬁgure; B) severe sexual or physical abuse; C)
maternal or paternal antipathy or neglect; D) more than two family ar-
rangements (the number of different caregivers with each of whom the
child lived for at least one year). Eachwas rated as either present (expo-
sure) or absent (no exposure). As only four participants reported being
brought up in a children's home or institution, this event was excluded
from the analysis.
2.3. 18F-DOPA PET imaging
All subjects were studied using 18F-DOPA positron emission tomog-
raphy (PET) imaging. Data were acquired on either a CTI/Siemens ECAT
HR+962 tomograph (11 healthy volunteers; 28 UHR) or a CTI/SiemensECAT HR++966 tomograph (9 healthy volunteers; 19 UHR) (Siemens
Molecular Imaging, Knoxville, TN, U.S.A.) as previously described
(Egerton et al., 2013; Howes et al., 2009). Study participants were
asked to fast for 12 h before imaging. Urine drug screens on themorning
of the scan to conﬁrmed absence of illicit substance use. All subjects re-
ceived carbidopa (150 mg) and entacapone (400 mg) orally 1 h before
imaging to reduce the formation of radiolabeled 18F-DOPAmetabolites.
All data were acquired in three-dimensional mode. A 10-minute (ECAT
HR + 962) or 5-minute (ECAT HR+ 966) transmission scan was per-
formed before radiotracer injection to correct for attenuation and scat-
ter. Thirty seconds after the start of PET image acquisition, 180 Mbq
(ECAT HR+ 962) or 150 MBq (ECAT HR+ 966) 18F-DOPA (±10%)
was administered by bolus intravenous injection. On both scanners,
emission data were acquired in list mode for 95 min, and rebinned
into 26 time frames.
Data were reconstructed using the 3D reprojection algorithms. Head
movement was corrected for by realigning denoised (Turkheimer et al.,
1999), nonattenuation-corrected dynamic images (Studholme et al.,
1996) and applying the transformation parameters to the correspond-
ing attenuation-corrected frames to create a movement-corrected dy-
namic image for analysis. Standardized striatal volumes of interest
(VOI) were delineated bilaterally on a single subject T1 magnetic reso-
nance image in Montreal Neurologic Institute (MNI) space. These VOI
included the limbic (ventral), associative and sensorimotor subdivisions
of the striatum, as according to previously deﬁned anatomical criteria
(Martinez et al., 2003; Mawlawi et al., 2001). The cerebellar reference
region was deﬁned using a probabilistic atlas (Hammers et al., 2003).
An 18F-DOPA template, also inMNI space, was then normalized togeth-
er with the VOI map to each individual PET summation image using
SPM5 (http://ﬁl.ion.ucl.ac.uk/spm; Wellcome Department of Imaging
Neuroscience, University College London). Graphical analysis, adapted
for a reference tissue input function (Patlak and Blasberg, 1985;
Turkheimer et al., 2006) as used to estimate presynaptic dopamine syn-
thesis capacity by calculating the rate of utilization of the dopamine pre-
cursor 18F-DOPA in the bilateral striatum, relative to the cerebellar
reference tissue (kicer min−1). To control for effects of scanner model
(Egerton et al., 2013), individual subject kicer values were converted to
z-scores (z = (kicer – scanner mean kicer)/scanner standard deviation
(SD)) for all analyses.
2.4. Statistical analyses
Statistical analysis was performed in SPSS version 19.0 (IBM Corpo-
ration, Armonk, New York). For demographic, clinical variables and
measures of childhood adversity, comparisons between Control and
UHR groups were performed using Fisher's Exact, Mann-Whitney U or
unpaired t-tests. The threshold for statistical signiﬁcance of P b 0.05.
The same approach was used to compare demographic and clinical var-
iables in individuals exposed or not exposed to each type of childhood
adversity. The impact of exposures to childhood adversity on striatal do-
pamine function were determined using independent samples t-tests
(exposure versus non-exposure). Effect size was calculated as Cohen's
d. Secondary analysis employed univariate ANOVA to explore potential
inﬂuences of group (Control versus UHR) and substance use on the re-
lationships between exposures to childhood adversity and dopamine
function. After conﬁrming normality of distribution, relationships be-
tween the severity of total prodromal symptoms (total CAARMS
score) in the UHR group and striatal dopamine function (z-score)
were explored Pearson's correlation coefﬁcient.
3. Results
3.1. Description of the UHR and control samples
There were no signiﬁcant differences between the UHR and Control
groups in demographic features or substance use (Table 1). As expected,
Table 1
Demographic characteristics, substance use and symptoms in the total sample, control and UHR groups.
Total (n = 67)
Control
(n = 20)
UHR
(n = 47) Statistic
Demographics
Male/female 39/28 12/8 27/20 P N 0.99
Age, mean ± sd 23.7 ± 4.5 23.8 ± 4.3 23.6 ± 4.6 T = 0.15; P= 0.88
Handedness, right/left 58/9 16/4 42/5 P= 0.43
Substance use
Non-smoker/smoker 35/22 13/7 22/25 P= 0.19
Non-drinker/drinker 17/50 4/16 13/34 P= 0.55
Cigarettes/day 3.8 ± 5.3 2.3 ± 3.8 4.5 ± 5.7 T = 1.58; P= 0.12
Alcohol units/week 6.7 ± 7.9 8.4 ± 8.6 6.0 ± 7.6 T = 0.26; P= 0.26
Cannabis 0/1/2/3/4 20/18/9/9/11 8/6/3/0/3 12/12/6/9/8 P N 0.99
Cocaine 0/1/2/3/4 43/14/4/4/2 16/3/0/1/0 27/11/4/3/2 P N 0.99
Amphetamine 0/1/2/3/4 52/11/1/3/0 18/2/0/0/0 34/9/1/3/0 P N 0.99
Ecstasy 0/1/2/3/4 39/18/6/4/0 14/3/3/0/0 25/15/3/4/0 P N 0.99
Ketamine 0/1/2/3/4 61/3/1/1/0 18/1/0/0/0 43/2/1/1/0 P N 0.99
Symptoms
CAARMS total 2.2 ± 2.8 41.3 ± 18.1 T = 9.59; P b 0.001
CAARMS positive 0.3 ± 0.6 7.7 ± 3.3 T = 10.0; P b 0.001
PANSS positive 7.0 ± 0.0 12.9 ± 4.3 T = 6.10; P b 0.001
PANSS negative 7.0 ± 0.0 11.5 ± 5.2 T = 3.90; P b 0.001
PANSS general 16.3 ± 0.6 27.2 ± 7.6 T = 6.44; P b 0.001
PANSS total 30.3 ± 0.6 51.7 ± 14.3 T = 6.68; P b 0.001
Hamilton anxiety 0.8 ± 1.2 11.9 ± 9.8 T = 5.03; P b 0.001
Hamilton depression 0.8 ± 1.2 11.6 ± 8.4 T = 5.77; P b 0.001
CAARMS: Comprehensive Assessment for At Risk Mental States; PANSS: Positive And Negative Syndrome Scale. For cannabis, cocaine, amphetamine, ecstasy and ketamine use, categories
of 0/1/2/3/4 indicate never used/very occasional or experimental use/occasional or monthly use/moderate or weekly use/severe or daily use respectively.
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1). Two of the UHR participants were taking antipsychotic medication
(olanzapine, 7.5 mg; quetiapine, 25 mg).
3.2. Experiences of childhood adversity
Within the total sample, the proportion of participants reporting
each type of childhood adversity ranged from 25% for more than two
family arrangements, to 62% for parental loss or separation (Table 2).
Within the total sample, there were no differences in demographic
measures or reported substance misuse between participants who re-
ported exposure to each type of childhood adversity and participants
who did not (Supplementary Table S1).
3.3. Presynaptic dopamine function following childhood adversity
In the associative striatum, dopamine function was signiﬁcantly
higher in participants who had experienced severe physical or sexual
abuse in childhood compared to those who had not (T63 = 2.92; P =
0.005; Table 3; Fig. 1, left). Dopamine function in this regionwas also el-
evated in participants who had experienced more than two family ar-
rangements compared to those who had not (T57 = 2.80; P = 0.007;
Table 3; Fig. 1, right). Both of these ﬁndings were associatedwithmedi-
um to large effect sizes (Cohen's d = 0.75 and 0.86 respectively).
Overall, of the twenty-six participants who reported sexual or phys-
ical abuse, eight also reported multiple family arrangements. When
both physical/sexual abuse and multiple family arrangements wereTable 2
Exposure to childhood adversity in the total sample, control and UHR groups.
Total Control UHR
P
value
Parental loss or separation 40/65 (62%) 10/20 (50%) 30/45 (67%) 0.27
Severe physical or sexual abuse 26/65 (40%) 4/20 (20%) 22/45 (49%) 0.03
Severe antipathy or neglect 21/59 (36%) 7/20 (35%) 14/39 (36%) N0.99
More than two family
arrangements
15/59 (25%) 3/20 (15%) 12/39 (31%) 0.22
Data are presented as the number and percentage of participants reporting exposure/
group total.included in the same model, the effect of multiple family arrangements
remained signiﬁcant (F1,58 = 5.96; P=0.018), while the effect of sex-
ual/physical abuse approached signiﬁcance (F1,58 = 3.50; P= 0.067).
The elevations in dopamine function remained signiﬁcant when the
two UHR individuals who were taking antipsychotic medication were
excluded from the analysis (sexual or physical abuse: T61 = 2.75;
P = 0.008; family arrangements: T55 = 2.85; P = 0.005), and when
group (UHR or Control) was included as a factor in the analyses (sexual
or physical abuse: F1,61 = 6.53; P = 0.01; more than two family ar-
rangements: F1,55=0.50; P=0.02). Therewere no signiﬁcant interac-
tions between group and adversity (sexual or physical abuse * group
interaction: F1,61 = 0.29; P = 0.59; more than two family arrange-
ments * group interaction: F1,55 = 0.27; P = 0.60). When analysis
was restricted to only the UHR group, these elevations approached sig-
niﬁcance (both P=0.06; Supplementary Table S2). The elevations in as-
sociative striatal dopamine function across UHR and Control
participants exposed to either sexual or physical abuse, or to more
than two family arrangements, also remained signiﬁcant when age,
gender, smoking or alcohol drinking status, or use of cannabis, cocaine,
amphetamine, ecstasy or ketamine were entered as ﬁxed factors in the
analyses (all P b 0.05). The same pattern of ﬁndings was evident when
the region of interest comprised the whole striatum, with both severe
physical or sexual abuse and multiple family arrangements again asso-
ciated with signiﬁcantly elevated dopamine function (Supplementary
Table S3), albeit with slightly smaller effect sizes than for the associative
striatum (d = 0.55 and 0.77 respectively).
Experiencingmore than two family arrangements was also associat-
ed with increased dopamine function in the sensorimotor striatum
(T57 = 2.40; P= 0.02; d = 0.76; Supplementary Table S3), but other-
wise dopamine function in the limbic and sensorimotor subregions
wasnot signiﬁcantly different in participantswhodid anddid not report
adverse childhood experiences.3.4. Childhood adversity in the UHR compared to control group
When exposures to each type of childhood adversity in UHR and vol-
unteer groups were compared, only physical or sexual abuse was more
commonly reported in the UHR group (P= 0.03; Table 2).
Table 3
Associative Striatal Dopamine Function and Childhood Adversity.
No exposure Exposure Statistic, effect size
Parental loss or separation 0.11 ± 0.71 −0.02 ± 1.14 T63 = 0.53; P= 0.60; d = 0.14
Severe physical or sexual abuse −0.25 ± 1.00 0.44 ± 0.84 T63 = 2.92; P= 0.005; d = 0.75
Severe antipathy or neglect 0.09 ± 0.94 −0.09 ± 1.03 T57 = 0.68; P= 0.50; d = 0.18
More than two family arrangements −0.17 ± 0.94 0.59 ± 0.83 T57 = 2.80; P= 0.007; d = 0.86
Dopamine function is expressed as the mean ± standard deviation z-scores for 18F-DOPA kicer values, representing presynaptic dopamine synthesis capacity.
Statistics in bold type indicate signiﬁcant results (P b 0.05).
174 A. Egerton et al. / Schizophrenia Research 176 (2016) 171–1763.5. Presynaptic dopamine function in the UHR compared to Control group
There were no signiﬁcant differences in striatal presynaptic dopa-
mine function between the UHR and Control groups (Table 4).
3.6. Relationships between dopamine function or childhood adversity and
symptoms in the UHR group
In the UHR group, the positive correlation between the severity of
total prodromal symptoms (total CAARMS score) and dopamine func-
tion (z-score) was signiﬁcant in the sensorimotor striatum (n = 47;
r = 0.30; P = 0.04) but not in the associative (n = 47; r = 0.20; P =
0.19), limbic (n = 47; r = 0.04; P = 0.80 or whole striatum (n = 47;
r = 0.23; P=0.13). There were no signiﬁcant differences in prodromal
symptom severity, anxiety or depression between individuals who had
or had not been exposed to each type of adversity (P N 0.05).
4. Discussion
An elevation in striatal dopamine function in adults who have been
exposed to childhood adversity is consistentwith animal studies linking
psychogenic stress to striatal dopaminergic elevation (Antelman et al.,
1980; Tidey andMiczek, 1996; Valenti et al., 2011), and with the recent
ﬁnding of elevated dopaminergic responses to amphetamine in healthy
volunteers exposed to childhood adversity (Oswald et al., 2014). Elevat-
ed dopamine function in the associative striatum was linked to severe
(sexual or physical) abuse, and to multiple family arrangements,
which may be a proxy marker for other stressors, including abuse
(Casanueva et al., 2014). Exposure to stressors in childhood and elevat-
ed brain dopamine function in early adulthoodhave each been indepen-
dently identiﬁed as major psychosocial and neurobiological risk factors
for psychosis (Howes et al., 2011b, 2012; Varese et al., 2012). Our ﬁnd-
ings link these factors in the same individuals, and illustrate howFig. 1. Presynaptic dopamine function (18F-DOPA kicer z-score) in the associative striatum is e
unstable family arrangements (right panel) during childhood.adverse environmental inﬂuences could impact on brain development
to alter the risk of a later psychotic illness (Howes et al., 2004; Selten
et al., 2013; Thompson et al., 2004).
Physical and sexual abuse can be viewed as a forms of intentional
harm which lead to enduring feelings of humiliation, which would place
our ﬁndings of increased striatal dopamine function in people who expe-
rienced these forms of abuse as consistent with the social defeat hypoth-
esis (Selten et al., 2013). In relation to this, it is perhaps interesting thatwe
found no association between dopamine function and parental loss or
separation, which are forms of trauma that do not necessarily or directly
involve intentional harm to the child (Selten et al., 2013).
The elevation in striatal dopamine function in subjectswith a history
of childhood adversity was not attributable to increased substance use
in these individuals, as they did not use illicit drugs more than individ-
uals who had not experienced adverse events in childhood, and the
ﬁndings remained signiﬁcant after controlling for substance misuse.
The relationships between childhood adverse events and dopamine
functionwere not corrected formultiple comparisons.While the report-
ed relationships between multiple family arrangements or physical or
sexual abuse and dopamine function in the associative striatum would
have survived correction, the relationship between multiple family ar-
rangements and dopamine in the sensorimotor striatum would not,
and therefore warrants conﬁrmation in a larger sample.
There was no evidence that the relationship between childhood ad-
versity and dopamine function was different in people with a high risk
of psychosis and healthy volunteers, although the relatively small num-
ber of participants in the healthy volunteer group may have limited the
power to observe a difference in the relationship between adversity and
dopamine function between these groups. While non-signiﬁcant, the
tendency towards higher levels of both striatal dopamine function and
of exposure to adversity in the UHR groupmay suggest that the signiﬁ-
cant relationships between adversity and elevated dopamine function
across UHR and healthy volunteers were primarily driven by the UHRlevated in young adults who experienced severe sexual or physical abuse (left panel) or
Table 4
Striatal dopamine function in the control and UHR groups.
Control (n = 20) UHR (n = 47) Statistic
Whole striatum 0.30 ± 1.01 0.54 ± 1.08 T= 0.88; P= 0.38
Associative striatum −0.20 ± 0.92 0.09 ± 1.02 T= 1.08; P= 0.28
Sensorimotor striatum 0.80 ± 1.24 1.10 ± 1.49 T= 0.78; P= 0.44
Limbic striatum 0.43 ± 1.99 0.55 ± 1.23 T= 0.31; P= 0.76
Dopamine function is expressed as themean± standard deviation z-scores for 18F-DOPA
ki
cer values, representing presynaptic dopamine synthesis capacity.
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ﬁndings approached signiﬁcance. The elevation in dopamine function
in those exposed to childhood adversity was particularly evident in
the associative subdivision of the striatum. This is the same striatal sub-
regionwhere themost robust dopaminergic ﬁndings are seen in schizo-
phrenia (Howes and Kapur, 2009; Kegeles et al., 2010).
The reported incidence of childhood adversities by both the UHR and
Control participants was relatively high. The volunteers were recruited
from a geographical area (in South East London) that has unusually
high levels of social and economic deprivation, and previous studies
have found that childhood adversity is relatively common among the
local population (Frissa et al., 2013). However meta-analysis in patients
with psychotic disorders suggest that they are nearly three times more
likely to have experienced childhood adversities than controls (Varese
et al., 2012).
In the individuals included in the present study, striatal dopamine
function was numerically but not signiﬁcantly elevated in the UHR com-
pared to healthy volunteer group. This cohort represents a subsample
from our previous studies that detected a signiﬁcant elevation in striatal
dopamine function in UHR compared to healthy volunteers overall
(Egerton et al., 2013; Howes et al., 2009). In UHR samples, the elevation
in dopamine function is less marked than in schizophrenia (Howes et
al., 2009; Mizrahi et al., 2012) and is mainly driven by the subgroup of
UHR subjects who later develop psychosis (Howes et al., 2011b). This,
along with the relatively high incidences of childhood adversities in the
healthy volunteer sample, may account for the overlap in values for
striatal dopamine synthesis capacity between the UHR and healthy
volunteers.
The putative relationship between childhood adversity, dopamine
function and risk of psychosis could be further investigated in a large pro-
spective study, which would determine how these factors relate to long-
term clinical outcome in UHR subjects. However, an effect of adverse psy-
chosocial experiences on dopamine function might only impact on the
risk of illness if there are interactions with other factors that have also
been implicated in psychosis, such as psychosocial exposures in adult-
hood (Morgan et al., 2014) or genetic risk factors (Modinos et al., 2013).
This would be consistent with current aetiological models of mental ill-
ness, which propose that these involve complex gene-environment,
gene-gene and environment-environment interactions (van Winkel et
al., 2013).
One limitation of the present study (and most other adult studies of
childhood abuse) is that the assessment of childhood adversity relied on
retrospective reporting, whichmay be inﬂuenced by current psychopa-
thology (Lysaker et al., 2005;Wolkind and Coleman, 1983). Nonetheless
patients' retrospective reports of abuse tend to be stable, accurate and
unaffected by current symptoms (Fisher et al., 2011). The low number
of exposures to some forms or markers of psychosocial stress (such as
being taken into local authority care) limited the analysis to relatively
common factors. These issues could be addressed in large scale prospec-
tive studies of children with detailed psychosocial evaluations, neuro-
imaging measures, and long term follow up.
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